Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
184.59
+1.99 (1.09%)
Aug 7, 2025, 12:31 PM - Market open
DFS Analyst Ratings
Total Analysts
17
Consensus Rating
Strong Buy
Price Target
$222.71
Upside
+20.65%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $245 → $254 | Buy | Maintains | $245 → $254 | +37.60% | Jul 29, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $213 → $243 | Strong Buy | Maintains | $213 → $243 | +31.64% | Jul 11, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $250 | Buy | Initiates | $250 | +35.44% | Jul 3, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $215 → $224 | Buy | Maintains | $215 → $224 | +21.35% | Jun 13, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $201 → $216 | Strong Buy | Maintains | $201 → $216 | +17.02% | Jun 9, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $196 → $201 | Strong Buy | Maintains | $196 → $201 | +8.89% | Jun 3, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $200 | Buy | Reiterates | $200 | +8.35% | May 12, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $180 → $250 | Hold → Buy | Upgrades | $180 → $250 | +35.44% | May 5, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $180 → $215 | Buy | Maintains | $180 → $215 | +16.47% | May 2, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $205 → $210 | Buy | Maintains | $205 → $210 | +13.77% | May 2, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $200 → $245 | Buy | Maintains | $200 → $245 | +32.73% | May 2, 2025 |
| Wedbush | Wedbush | Buy Maintains $181 → $212 | Buy | Maintains | $181 → $212 | +14.85% | May 2, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $260 → $280 | Buy | Maintains | $260 → $280 | +51.69% | May 2, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $205 | Buy | Initiates | $205 | +11.06% | Apr 16, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $168 → $200 | Buy | Maintains | $168 → $200 | +8.35% | Mar 18, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $170 → $200 | Buy | Maintains | $170 → $200 | +8.35% | Feb 25, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.